Matthew Fero, MD, FACP

My research interest is focused on the development of novel therapeutic agents for the treatment of hematological malignancies. Towards this aim, I am serving in three different leadership positions: 1) I am the director of the UNM Bone Marrow Transplant Bone Marrow Transplant: A bone marrow transplant (BMT) is also called a stem cell transplant (SCT) or hematopoietic stem cell transplant (HSCT).The procedure replaces unhealthy blood-forming stem cells with healthy ones and offers some patients the possibility of a cure. But for many patients, a BMT is not an option due… and Cell Therapy Program, which has brought autologous hematopoietic stem cell transplant technology to New Mexico, with the intent of introducing allogeneic stem cell transplant allogeneic stem cell transplant: A procedure where bone marrow stem cells are taken from a genetically matched donor (a brother, sister, or unrelated donor) and given to the patient through an intravenous (IV) line. In time, donated stem cells start making new, healthy blood cells. and both CAR-T therapy in the near future. Our program is currently undergoing FACT accreditation to further this aim. 2) I am the leader of the Hematology Clinical Working Group, a committee which reviews and prioritizes all clinical trials clinical trials: Clinical research is at the heart of all medical advances, identifying new ways to prevent, detect or treat disease. If you have a bone marrow failure disease, you may want to consider taking part in a clinical trial, also called a research study. Understanding Clinical Trials Clinical… for hematological malignancies at UNM and affiliate NCORP community sites. 3) My laboratory uses preclinical models to identify novel therapeutic targets for hematological malignancies, and to test the therapeutic efficacy of novel agents. We have expertise both the development of novel targeted and transgenic mice, as well as human tumor xenograft models to elucidate the oncogenic interactions of genes and carcinogenic compounds, in order to understand their potential risks and pathogenic mechanisms. In addition to this basic science work, my laboratory is interested in the fundamental processes of hematopoiesis hematopoiesis: (hi-mat-uh-poy-EE-suss) The process of making blood cells in the bone marrow. and the development of novel cell therapeutic agents. We assist the Cancer Center in validating autologous stem cell products that have been transported from our processing facility prior to stem cell transplantation, and we are interested in contributing to the creation of a Cell Therapy Developmental laboratory which would advance the therapeutic transplational capabilities of the UNM BMT program.